Cargando…

Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis

BACKGROUND: Growing body of evidence suggest the association between SNP − 11377 C > G and SNP + 276 G > T polymorphisms of adiponectin gene with type 2 diabetes (T2D). However, these findings have not been conclusive and consistent. The present study quantitatively evaluates the data on the a...

Descripción completa

Detalles Bibliográficos
Autores principales: Alimi, Mahrokh, Goodarzi, Mohammad Taghi, Nekoei, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596906/
https://www.ncbi.nlm.nih.gov/pubmed/34789338
http://dx.doi.org/10.1186/s13098-021-00749-x
_version_ 1784600494680834048
author Alimi, Mahrokh
Goodarzi, Mohammad Taghi
Nekoei, Mehdi
author_facet Alimi, Mahrokh
Goodarzi, Mohammad Taghi
Nekoei, Mehdi
author_sort Alimi, Mahrokh
collection PubMed
description BACKGROUND: Growing body of evidence suggest the association between SNP − 11377 C > G and SNP + 276 G > T polymorphisms of adiponectin gene with type 2 diabetes (T2D). However, these findings have not been conclusive and consistent. The present study quantitatively evaluates the data on the association between DIPOQ − 11377C/G, and + 276G/T polymorphisms and risk of T2D through a meta-analysis. METHODS: A systematic search was performed in the PubMed, Web of science, Scopus and Cochrane library databases to extract published studies according to the inclusion criteria. Among the 741 studies, 391 of them were screened as full text and 31 studies were finally included in the meta-analysis. Analysis of data was performed using random-effects model. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to analyze the strength of association. Subgroup and meta-regression analyses were performed to identify the potential source of heterogeneity. RESULTS: The pooled analysis showed that there was no statistically significant association between genotypes of CC (OR = 0.76, 95% CI: 0.53–1.09, P = 0.14), CG (OR = 0.93, 95% CI: 0.72–1.20, P = 0.58) and GG (OR = 1, 95% CI: 0.80–1.26, P = 0.94) ADIPO − 11377 polymorphism with increased risk of T2D. In addition, the results revealed a trend toward an increased risk of T2D for the SNP + 276 TT genotype (OR = 0.87, 95% CI: 0.77–0.98, P = 0.026) as compared with the GT and GG genotypes. Subgroup analysis by ethnicity indicated significant association between the TT genotype of the SNP + 276 and increased risk of T2D among Europeans. Met-regression demonstrated significant association between the GT genotype of + 276 polymorphism with risk of T2D in male individuals (slope: 0.0006; 95% CI: 0.0002–0.0009; P < 0.001). CONCLUSIONS: Collectively, our findings demonstrated a positive association between ADIPOQ + 276 G > T polymorphism with increased risk of T2D in male individuals with European ethnicity. GRAPHICAL ABSTRACT: [Image: see text]
format Online
Article
Text
id pubmed-8596906
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85969062021-11-17 Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis Alimi, Mahrokh Goodarzi, Mohammad Taghi Nekoei, Mehdi Diabetol Metab Syndr Research BACKGROUND: Growing body of evidence suggest the association between SNP − 11377 C > G and SNP + 276 G > T polymorphisms of adiponectin gene with type 2 diabetes (T2D). However, these findings have not been conclusive and consistent. The present study quantitatively evaluates the data on the association between DIPOQ − 11377C/G, and + 276G/T polymorphisms and risk of T2D through a meta-analysis. METHODS: A systematic search was performed in the PubMed, Web of science, Scopus and Cochrane library databases to extract published studies according to the inclusion criteria. Among the 741 studies, 391 of them were screened as full text and 31 studies were finally included in the meta-analysis. Analysis of data was performed using random-effects model. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to analyze the strength of association. Subgroup and meta-regression analyses were performed to identify the potential source of heterogeneity. RESULTS: The pooled analysis showed that there was no statistically significant association between genotypes of CC (OR = 0.76, 95% CI: 0.53–1.09, P = 0.14), CG (OR = 0.93, 95% CI: 0.72–1.20, P = 0.58) and GG (OR = 1, 95% CI: 0.80–1.26, P = 0.94) ADIPO − 11377 polymorphism with increased risk of T2D. In addition, the results revealed a trend toward an increased risk of T2D for the SNP + 276 TT genotype (OR = 0.87, 95% CI: 0.77–0.98, P = 0.026) as compared with the GT and GG genotypes. Subgroup analysis by ethnicity indicated significant association between the TT genotype of the SNP + 276 and increased risk of T2D among Europeans. Met-regression demonstrated significant association between the GT genotype of + 276 polymorphism with risk of T2D in male individuals (slope: 0.0006; 95% CI: 0.0002–0.0009; P < 0.001). CONCLUSIONS: Collectively, our findings demonstrated a positive association between ADIPOQ + 276 G > T polymorphism with increased risk of T2D in male individuals with European ethnicity. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2021-11-17 /pmc/articles/PMC8596906/ /pubmed/34789338 http://dx.doi.org/10.1186/s13098-021-00749-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Alimi, Mahrokh
Goodarzi, Mohammad Taghi
Nekoei, Mehdi
Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
title Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
title_full Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
title_fullStr Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
title_full_unstemmed Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
title_short Adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
title_sort adiponectin gene polymorphisms and risk of type 2 diabetes: an updated evidence for meta-analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596906/
https://www.ncbi.nlm.nih.gov/pubmed/34789338
http://dx.doi.org/10.1186/s13098-021-00749-x
work_keys_str_mv AT alimimahrokh adiponectingenepolymorphismsandriskoftype2diabetesanupdatedevidenceformetaanalysis
AT goodarzimohammadtaghi adiponectingenepolymorphismsandriskoftype2diabetesanupdatedevidenceformetaanalysis
AT nekoeimehdi adiponectingenepolymorphismsandriskoftype2diabetesanupdatedevidenceformetaanalysis